$USAQ
QHSLab Inc Stock $usaq

$usaq Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000149315222022959 Filed on August 15, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$269.3K	$350.8K	$355.3K
YoY Change	-17.0%	-23.0%	16.75%
Cost Of Revenue	$143.7K	$180.6K	$166.6K
YoY Change	-14.14%	-27.32%	-2.41%
Gross Profit	$125.6K	$170.2K	$188.7K
YoY Change	-20.04%	-17.82%	41.26%
Gross Profit Margin	46.64%	48.52%	53.1%
Selling, General & Admin	$262.6K	$243.9K	$202.8K
YoY Change	-20.8%	-17.78%	11.54%
% of Gross Profit	209.05%	143.27%	107.48%
Research & Development	$48.41K	$58.62K	$28.98K
YoY Change	146.84%	283.83%	3.43%
% of Gross Profit	38.54%	34.44%	15.36%
Depreciation & Amortization	$36.65K	$36.64K	$18.03K
YoY Change	103.27%
% of Gross Profit	29.18%	21.53%	9.56%
Operating Expenses	$329.0K	$320.5K	$249.8K
YoY Change	-10.88%	2.78%	19.06%
Operating Profit	-$203.4K	-$150.3K	-$61.13K
YoY Change	-4.1%	43.51%	-19.83%
Interest Expense	$106.7K	$129.1K	-$127.2K
YoY Change	-220.35%	1600.05%	1119.18%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$310.1K	-$279.4K	-$190.3K
YoY Change	3.11%	148.72%	119.52%
Income Tax
% Of Pretax Income
Net Earnings	-$310.1K	-$279.4K	-$190.3K
YoY Change	3.11%	148.72%	119.53%
Net Earnings / Revenue	-115.15%	-79.64%	-53.56%
Basic Earnings Per Share	-$0.03	-$0.03	-$0.02
Diluted Earnings Per Share	-$0.03	-$31.76K	-$21.67K
COMMON SHARES
Basic Shares Outstanding	9.066M shares	8.798M shares	8.780M shares
Diluted Shares Outstanding	9.068M shares	8.798M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$237.9K	$97.17K	$155.6K
YoY Change	-56.21%	-33.42%	349.99%
Cash & Equivalents	$237.9K	$97.17K	$155.6K
Short-Term Investments
Other Short-Term Assets	$49.34K	$29.18K	$71.89K
YoY Change	32.21%	92.73%	466.51%
Inventory	$97.96K	$54.16K	$73.15K
Prepaid Expenses
Receivables	$58.09K	$112.0K	$96.09K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$443.3K	$292.5K	$396.7K
YoY Change	-38.45%	2.57%	121.75%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles	$1.522M	$1.540M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.709M	$1.745M	$1.782M
YoY Change	-1.49%	2.1%	2941.67%
TOTAL ASSETS
Total Short-Term Assets	$443.3K	$292.5K	$396.7K
Total Long-Term Assets	$1.709M	$1.745M	$1.782M
Total Assets	$2.152M	$2.038M	$2.179M
YoY Change	-12.33%	2.17%	817.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$150.0K	$113.5K	$33.05K
YoY Change	71.31%	150.94%	-57.56%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$297.2K	$327.1K	$614.0K
YoY Change
Long-Term Debt Due	$297.2K	$327.1K	$342.2K
YoY Change	-61.74%	4.99%
Total Short-Term Liabilities	$1.657M	$1.353M	$1.036M
YoY Change	88.4%	267.06%	1047.57%
LONG-TERM LIABILITIES
Long-Term Debt	$209.0K	$275.3K	$457.8K
YoY Change	-76.03%	-71.23%	0.1%
Other Long-Term Liabilities	$0.00	$0.00	$8.990K
YoY Change	-100.0%	-100.0%	-92.07%
Total Long-Term Liabilities	$209.0K	$275.3K	$466.8K
YoY Change	-78.9%	-74.29%	-18.21%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.657M	$1.353M	$1.036M
Total Long-Term Liabilities	$209.0K	$275.3K	$466.8K
Total Liabilities	$1.866M	$1.629M	$1.502M
YoY Change	-0.23%	13.15%	127.3%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.299M	-$2.989M
YoY Change
Common Stock	$932.00	$882.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$286.2K	$409.1K	$676.1K
YoY Change
Total Liabilities & Shareholders Equity	$2.152M	$2.038M	$2.179M
YoY Change	-12.33%	2.17%	817.38%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$310.1K	-$279.4K	-$190.3K
YoY Change	3.11%	148.72%	119.53%
Depreciation, Depletion And Amortization	$36.65K	$36.64K	$18.03K
YoY Change	103.27%
Cash From Operating Activities	-$183.1K	$39.32K	-$137.4K
YoY Change	33.91%	-159.12%	317.85%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	-$37.12K
YoY Change	-100.0%	-100.0%	38.1%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00	-$37.12K
YoY Change	-100.0%	-100.0%	38.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	323.9K	-97.70K	43.25K
YoY Change	-43.9%	-145.23%
NET CHANGE
Cash From Operating Activities	-183.1K	39.32K	-137.4K
Cash From Investing Activities	0.000	0.000	-37.12K
Cash From Financing Activities	323.9K	-97.70K	43.25K
Net Change In Cash	140.8K	-58.38K	-131.3K
YoY Change	-64.58%	-152.42%
FREE CASH FLOW
Cash From Operating Activities	-$183.1K	$39.32K	-$137.4K
Capital Expenditures	$0.00	$0.00	-$37.12K
Free Cash Flow	-$183.1K	$39.32K	-$100.3K
YoY Change	95.72%	-238.45%	1569.05%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000856984
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization		usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization		usd
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-19041
CY2021Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization		usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Stock Issued1 StockIssued1		usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2021Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization		usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization		usd
CY2022Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Entity Registrant Name EntityRegistrantName	QHSLab, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	30-1104301
	dei	Entity Address Address Line1 EntityAddressAddressLine1	901 Northpoint Parkway
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 302
	dei	Entity Address Address Line3 EntityAddressAddressLine3	West Palm
	dei	Entity Address City Or Town EntityAddressCityOrTown	Beach
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33407
	dei	City Area Code CityAreaCode	(929)
	dei	Local Phone Number LocalPhoneNumber	379-6503
	dei	Security12g Title Security12gTitle	Common Stock, $0.0001 Par Value
	dei	Trading Symbol TradingSymbol	USAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9065508	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	97172	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	286855	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	112008	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	70474	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	54157	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	65740	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	29182	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2208497	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	350816	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	455622	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	706146	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	22713	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	292519	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	445782	usd
CY2022Q2	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	204775	usd
CY2021Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	186271	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1540388	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1576444	usd
CY2022Q2	us-gaap	Assets Assets	2037682	usd
CY2021Q4	us-gaap	Assets Assets	2208497	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	113500	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	20370	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	100805	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	58615	usd
CY2022Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	327099	usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	253865	usd
CY2022Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	811879	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	542104	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1353283	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	874954	usd
CY2021Q4	USAQ	Accrued Interest Expenses Non Current AccruedInterestExpensesNonCurrent	6521	usd
CY2022Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	275268	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	402956	usd
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	100000	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	275268	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	509477	usd
CY2022Q2	us-gaap	Liabilities Liabilities	1628551	usd
CY2021Q4	us-gaap	Liabilities Liabilities	1384431	usd
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8815508	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8815508	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8756093	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8756093	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	882	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	876	usd
CY2021Q4	us-gaap	Deferred Compensation Equity DeferredCompensationEquity	6968	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3396461	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3348681	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2988584	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2518895	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	409131	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	824066	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2037682	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	759957	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	180608	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	248502	usd
	us-gaap	Cost Of Revenue CostOfRevenue	347249	usd
	us-gaap	Cost Of Revenue CostOfRevenue	419258	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	170208	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	207120	usd
	us-gaap	Gross Profit GrossProfit	358897	usd
	us-gaap	Gross Profit GrossProfit	340699	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	119772	usd
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	161619	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	233067	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	273308	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	124093	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	134964	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	213608	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	205090	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	58615	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15271	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	87593	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	43292	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18028	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	36056	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	320508	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	311854	usd
	us-gaap	Operating Expenses OperatingExpenses	570324	usd
	us-gaap	Operating Expenses OperatingExpenses	521690	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-150300	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-104734	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-211427	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-180991	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	129085	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	7593	usd
	us-gaap	Interest Expense InterestExpense	256242	usd
	us-gaap	Interest Expense InterestExpense	18022	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2020	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-279385	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-112327	usd
	us-gaap	Net Income Loss NetIncomeLoss	-469689	usd
	us-gaap	Net Income Loss NetIncomeLoss	-199013	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8797782	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7206586	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8815508	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6966046	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	824066	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	3484	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	27925	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2020	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	8920	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-190304	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	676111	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	3484	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	8921	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-279385	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	409131	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-608326	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	581	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	194211	usd
CY2021Q1	USAQ	Amortization Of Unearned Compensation AmortizationOfUnearnedCompensation	67812	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	8920	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-86686	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-423488	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-423488	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	20850	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	132075	usd
CY2021Q2	USAQ	Amortization Of Unearned Compensation AmortizationOfUnearnedCompensation	36594	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	8921	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	862500	usd
CY2021Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	30000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-112327	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	555125	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	555125	usd
	us-gaap	Net Income Loss NetIncomeLoss	-469689	usd
	us-gaap	Net Income Loss NetIncomeLoss	-199013	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	11222	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	54671	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	194775	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	17841	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	17841	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	6968	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	125837	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2020	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	52756	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1923	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-11583	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-34210	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6469	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3543	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	93130	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-100190	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	15299	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	5646	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	23295	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	86000	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	182954	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-54454	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	216000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-189683	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	51605	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	286855	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	17885	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-98110	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-99404	usd
	us-gaap	Payments For Software PaymentsForSoftware	37119	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	94342	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	97172	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	145947	usd
	us-gaap	Payments For Software PaymentsForSoftware	64991	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37119	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-64991	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	30000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	100000	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	128500	usd
	us-gaap	Interest Paid Net InterestPaidNet	38172	usd
	us-gaap	Interest Paid Net InterestPaidNet	21	usd
	USAQ	Debt And Accrued Interest Converted To Shares Of Common Stock DebtAndAccruedInterestConvertedToSharesOfCommonStock	27925	usd
	USAQ	Debt And Accrued Interest Converted To Shares Of Common Stock DebtAndAccruedInterestConvertedToSharesOfCommonStock	326286	usd
	us-gaap	Stock Issued1 StockIssued1	1612500	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80B_eus-gaap--NatureOfOperations_zuHozscwIgCi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1. <span id="xdx_82A_zqkY4OMeZcSj">The Company</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QHSLab, Inc. (f/k/a USA Equities Corp.) (the “Company”, or the “Registrant”) was incorporated in Delaware on September 1, 1983<span style="background-color: white">. </span>In 2015, the Company changed its name to USA Equities Corp. On September 23, 2021, the Company changed its state of incorporation from Delaware to Nevada as a result of a merger with and into its newly formed wholly-owned subsidiary, USA Equities Corp., a Nevada corporation (“USA Equities Nevada”), the surviving entity pursuant to an Agreement and Plan of Merger. The reincorporation was approved by the stockholders of the Company and USA Equities Nevada is deemed to be the successor to USA Equities Corp, the Delaware corporation. <span style="background-color: white">On April 19, 2022, the Company changed its name to QHSLab, Inc.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is a medical device technology and software-as-a-service (“SaaS”) company focused on enabling primary care physicians (“PCP’s”) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zyXTrJPZmzP1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_z4tHWvhFppf7">Use of Estimates</span>:</i> The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statement and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from the estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2022Q2	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	204775	usd
CY2021Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	186271	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	18615	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	0	usd
	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	0	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	87593	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	43292	usd
	USAQ	Net Operating Losses Carryforwards Expire Date NetOperatingLossesCarryforwardsExpireDate	begin to expire in 2027
CY2022Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	2988584	usd
CY2022Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	123230	usd
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	70474	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	11222	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	112008	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	70474	usd
CY2022Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	223390	usd
CY2021Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	186271	usd
CY2022Q2	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	18615	usd
CY2022Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	204775	usd
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	186271	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1612500	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1612500	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	72112	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	36056	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1540388	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1576444	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	18615	usd
CY2021	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	0	usd
	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	0	usd
CY2021	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	0	usd
CY2021Q2	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	1612500	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	36056	usd
CY2022Q2	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	527794	usd
CY2021Q4	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	644158	usd
CY2022Q1	us-gaap	Proceeds From Loans ProceedsFromLoans	128500	usd
CY2022Q1	us-gaap	Payments For Loans PaymentsForLoans	16305	usd
CY2022Q2	us-gaap	Loans Payable LoansPayable	88984	usd
CY2021Q4	us-gaap	Loans Payable LoansPayable	16793	usd
CY2022Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	856000	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	881000	usd
CY2022Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	44121	usd
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	238896	usd
CY2022Q2	USAQ	Convertible Notes Payable Debt Discount And Issuance Costs ConvertibleNotesPayableDebtDiscountAndIssuanceCosts	811879	usd
CY2021Q4	USAQ	Convertible Notes Payable Debt Discount And Issuance Costs ConvertibleNotesPayableDebtDiscountAndIssuanceCosts	642104	usd
CY2022Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	811879	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	542104	usd
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	100000	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	34191	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	37830	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	6290	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	15446	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	204835	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	34060	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2126647	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1189793	shares
	us-gaap	Share Based Compensation ShareBasedCompensation	17841	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	17841	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6968	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	125837	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	18243	usd
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1100000	shares
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P9M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.12
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0021	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y6M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.763	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure

Files In Submission

Name	View Source	Status
0001493152-22-022959-index-headers.html	Edgar Link	pending
0001493152-22-022959-index.html	Edgar Link	pending
0001493152-22-022959.txt	Edgar Link	pending
0001493152-22-022959-xbrl.zip	Edgar Link	pending
ex31.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
usaq-20220630.xsd	Edgar Link	pending
usaq-20220630_cal.xml	Edgar Link	unprocessable
usaq-20220630_def.xml	Edgar Link	unprocessable
usaq-20220630_lab.xml	Edgar Link	unprocessable
usaq-20220630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$USAQ
QHSLab Inc Stock $usaq

2022 Q3 Form 10-Q Financial Statement

#000149315222022959 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$USAQ QHSLab Inc Stock $usaq

2022 Q3 Form 10-Q Financial Statement

#000149315222022959 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$USAQ
QHSLab Inc Stock $usaq